Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders of KPC
Legal Opinions of Beijing Deheng (Kunming) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Kunming Pharmaceutical Group Co., Ltd.
Rules of procedure for the board of directors of KPC Group Co., Ltd. (Revised in April 2024)
Articles of Association of KPC Group Co., Ltd. (Revised in April 2024)
Materials of the 2024 3rd Extraordinary General Meeting of Shareholders of KPC Group
Notice of KPC Group on Convening the Third Extraordinary General Meeting of Shareholders in 2024
An indicative announcement of KPC Group regarding the publication of the 2023 results announcement by China Resources Pharmaceutical Group Co., Ltd., the indirect controlling shareholder of the controlling shareholder
Special report by the board of directors of KPC on the self-inspection of the independence of independent directors
KPC 2023 Audit and Risk Control Committee Performance Report
KPC 2023 Internal Control Evaluation Report
Report by the Audit and Risk Control Committee of the Board of Directors of KPC Group on the performance of supervisory duties by accounting firms in 2023
Announcement of KPC Group on preparation for impairment of assets accrued for 2023
Rules of procedure for the board of directors of KPC Group Co., Ltd.
Implementation Rules of the Audit and Risk Control Committee of the Board of Directors of KPC Group Co., Ltd.
Announcement of KPC Group on the revision of the “Articles of Association”
KPC Group's Announcement on 2024 Financing Amounts
Legal Opinions of Beijing Deheng (Kunming) Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Kunming Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of KPC Group
Announcement of KPC on Obtaining a Notice of Approval for Drug Supplementation Applications
Announcement of KPC on acceptance of drug clinical trial applications
No Data